The dulaglutide (Trulicity) shortage was resolved in June 2025
These appointments are opportunities to assess the medication's effectiveness, address any concerns, and make necessary adjustments to your diabetes management plan
Semaglutide activates GLP-1 receptors throughout your digestive tract, which can slow gastric emptying and reduce appetitebut this mechanism sometimes creates constipation or bloating in the first 48 weeks
Further, FDAs GLP-1 webpage provides more detailed guidance on key risk areas, including: (i) import alerts intended to prevent GLP1 active pharmaceutical ingredients (APIs) with quality concerns from entering the United States
A client in a medically supervised caloric restriction protocol is, by definition, in a deficit
Semorelin, while effective at increasing growth hormone levels, lacks the targeted fat-reduction properties of Tesamorelin, making it less impactful for those focused on weight loss